Graham Collins/X
Dec 9, 2024, 20:06
Graham Collins: Real world 2nd line Lisocabtagene maraleucel
Graham Collins, Associate Professor, Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared on X:
“Real world 2nd line Lisocabtagene maraleucel.
– 156 patients, med FU 6 months, many not transform-eligible.
– 70% CRR, 6mo PFS 61%.
– 6% G3/4 ICANS.
– Slight reduction in refractory vs early relapse and with age >70 years.
Largely reflects Transform data. Hoping it will come to UK soon.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 9, 2024, 20:06
Dec 9, 2024, 19:30
Dec 9, 2024, 19:25